Used in the pharmaceutical industry as a key intermediate in the synthesis of kinase inhibitors, particularly for targeted cancer therapies. Its structure enables selective binding to specific enzyme targets involved in cell signaling pathways, making it valuable in the development of drugs for treating solid tumors and hematological malignancies. The compound's chiral center is critical for biological activity, ensuring high potency and reduced off-target effects in final drug formulations. It is also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved metabolic stability and bioavailability.